Equity Overview
Price & Market Data
Price: $9.00
Daily Change: +$0.20 / 2.22%
Range: $8.61 - $9.20
Market Cap: $75,191,504
Volume: 244,541
Performance Metrics
1 Week: -11.99%
1 Month: 11.87%
3 Months: 273.4%
6 Months: -28.30%
1 Year: -64.49%
YTD: 268.6%
Company Details
Employees: 15
Sector: Commercial services
Industry: Miscellaneous commercial services
Country: United States
Details
CervoMed Inc., a biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. Its lead drug candidate is neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, frontotemporal dementia, and ischemic stroke recovery. The company develops EIP200 for central nervous system which is in preclinical trials. The company was founded in 2010 and is headquartered in Boston, Massachusetts.